<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Zoll Medical Corporation</title>
	<atom:link href="http://www.stockbloghub.com/tag/zoll-medical-corporation/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611</link>
		<comments>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611#comments</comments>
		<pubDate>Tue, 20 Mar 2012 02:13:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94611</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609</link>
		<comments>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609#comments</comments>
		<pubDate>Thu, 08 Mar 2012 19:28:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94609</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2012/01/27/zoll-zoll-medical-corporation-bull-of-the-day-4/90966</link>
		<comments>http://www.stockbloghub.com/2012/01/27/zoll-zoll-medical-corporation-bull-of-the-day-4/90966#comments</comments>
		<pubDate>Fri, 27 Jan 2012 17:26:30 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=90966</guid>
		<description><![CDATA[We retain our Outperform recommendation on ZOLL Medical Corp. (ZOLL) following its forecast-topping first quarter results. Revenues and earnings for the quarter beat the Zacks Consensus Estimates, driven by strong sales from the company&#8217;s LifeVest and temperature management businesses. The company witnessed healthy sales across the North American hospital and pre-hospital markets. We are pleased with ZOLL&#8217;s solid fundamentals and its broad product range. Moreover, its significant international presence should also drive growth. The company has completed multiple acquisitions and is seeking more such lucrative transactions to aid growth. Management&#8217;s outlook for fiscal 2012 is encouraging with sales are expected to grow at a healthy double-digit clip on the strength of the company&#8217;s core defibrillator business. ZOLL MEDICAL CO (ZOLL): Free Stock Analysis Report]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/27/zoll-zoll-medical-corporation-bull-of-the-day-4/90966/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(STJ) New Year Bets from MedTech</title>
		<link>http://www.stockbloghub.com/2012/01/06/stj-new-year-bets-from-medtech/89062</link>
		<comments>http://www.stockbloghub.com/2012/01/06/stj-new-year-bets-from-medtech/89062#comments</comments>
		<pubDate>Fri, 06 Jan 2012 21:03:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89062</guid>
		<description><![CDATA[Picking the right stock is never easy, especially in a difficult and volatile market. There are thousands of stocks to choose from and many investors eventually end up boiling the ocean. The U.S. economy continues to be cramped by a spate of headwinds including a still unstable job market, high debt, a soft housing sector and last but surely not the least, the European sovereign debt contagion, which have hit industries across the board. The recent EU summit did not bring out any concrete solution to staunch the debt crisis which began in Greece in 2009. The healthcare sector, traditionally revered as a safe haven for investors and one of the most preferred areas to take cover in the midst of market volatility, has been somewhat proved not immune to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/06/stj-new-year-bets-from-medtech/89062/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical&#8217;s AutoPulse Tapped by WSPR Szczecin</title>
		<link>http://www.stockbloghub.com/2011/11/30/zoll-zoll-medicals-autopulse-tapped-by-wspr-szczecin/87705</link>
		<comments>http://www.stockbloghub.com/2011/11/30/zoll-zoll-medicals-autopulse-tapped-by-wspr-szczecin/87705#comments</comments>
		<pubDate>Wed, 30 Nov 2011 19:57:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87705</guid>
		<description><![CDATA[Resuscitation devices maker ZOLL Medical (ZOLL) said that its new AutoPulse Plus cardiac support pumps has been bought by WSPR Szczecin, the biggest emergency service operator in Poland. The Polish entity has purchased 49 such devices to equip its fleet of ambulances. The innovative AutoPulse Plus pumps enables rescuers to defibrillate without stopping chest compressions for defibrillation. WSPR Szczecin selected the device based on positive user experience following a 12-month evaluation. The Massachusetts-based company also noted that WSPR Szczecin has initiated a program to upgrade to its new E Series Monitor/Defibrillator from the existing M Series platform. The E Series connects directly to AutoPulse Plus, which enables real-time integrated operation of these devices, thereby allowing consistent, uninterrupted chest compressions with timed shock delivery. Chest compressions, if stopped during defibrillation, results ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/30/zoll-zoll-medicals-autopulse-tapped-by-wspr-szczecin/87705/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2011/11/21/zoll-zoll-medical-corporation-bull-of-the-day-3/87320</link>
		<comments>http://www.stockbloghub.com/2011/11/21/zoll-zoll-medical-corporation-bull-of-the-day-3/87320#comments</comments>
		<pubDate>Mon, 21 Nov 2011 18:47:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87320</guid>
		<description><![CDATA[We upgrade our recommendation on ZOLL Medical Corp. (ZOLL) to Outperform following its forecast-topping fourth quarter results. Revenues and earnings for the quarter outperformed the Zacks Consensus Estimates, driven by strong contributions from the company&#8217;s LifeVest and temperature management franchises, backed by higher sales in the North American hospital market. We are pleased with ZOLL&#8217;s solid fundamentals and its broad product range. Moreover, its significant international presence should also drive growth. The company has completed multiple acquisitions and is seeking more such lucrative transactions to aid growth. Management&#8217;s outlook for fiscal 2012 appears encouraging with sales are expected to grow at a healthy double-digit clip on the strength of the company&#8217;s core defibrillator business. Our price target of $53 is based on 27.3x our fiscal 2012 EPS estimate. ZOLL MEDICAL ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/21/zoll-zoll-medical-corporation-bull-of-the-day-3/87320/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Technology Industry Stock Outlook &#8211; November 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069</link>
		<comments>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069#comments</comments>
		<pubDate>Fri, 18 Nov 2011 18:52:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[THOR]]></category>
		<category><![CDATA[Thoratec Corporation]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87069</guid>
		<description><![CDATA[The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures, reimbursement pressure and the impact of health care reform continues to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. The beleaguered U.S. implantable defibrillator market continues to bother cardiac devices makers, as reflected by sustained implant volume pressure. On the other hand, companies in the orthopedic domain remain affected by a still choppy reconstructive implant market as they faced sustained pressure across hip, knee and spine businesses in the third quarter (albeit to a lesser extent vis-à-vis the sequentially prior quarter). Although a number of these issues are ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; Sept. 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743</link>
		<comments>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743#comments</comments>
		<pubDate>Thu, 08 Sep 2011 19:53:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82743</guid>
		<description><![CDATA[June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected to linger over the second-half of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The highly-regulated medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; June 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179</link>
		<comments>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179#comments</comments>
		<pubDate>Thu, 23 Jun 2011 01:09:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77179</guid>
		<description><![CDATA[A host of macro headwinds (including price and procedure volume pressure) which hit the MedTech industry last year continued to haunt the sector during the March quarter and encumber growth. Although a number of these issues are expected to linger through the remainder of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices industry continues to grow at a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/05/09/zoll-zoll-analyst-maintains-shares-at-neutral/73453</link>
		<comments>http://www.stockbloghub.com/2011/05/09/zoll-zoll-analyst-maintains-shares-at-neutral/73453#comments</comments>
		<pubDate>Mon, 09 May 2011 14:02:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73453</guid>
		<description><![CDATA[We maintain our Neutral recommendation on resuscitation devices maker ZOLL Medical (ZOLL). Revenues and earnings for second-quarter fiscal 2011 beat the Zacks Consensus Estimates driven by strong contributions from the Massachusetts-based company’s LifeVest and temperature management businesses, backed by healthy international growth. Revenues from ZOLL Medical’s North American hospital market clipped 2% year over year, as sales from its U.S. military business tumbled 17.5% in the quarter. The company’s North American pre-hospital market remains affected by a still weak capital spending backdrop with sales dipping 4% in the second quarter. ZOLL Medical’s flagship LifeVest business continues its strong momentum with revenues propelling 60% in the quarter. However, sales from its AutoPulse cardiac support pump tanked 34%, hit by tight budgets for equipment purchases in the emergency medical services (“EMS”) channel. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/09/zoll-zoll-analyst-maintains-shares-at-neutral/73453/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical&#8217;s Propaq Cleared in Canada</title>
		<link>http://www.stockbloghub.com/2011/04/13/zoll-zoll-medicals-propaq-cleared-in-canada/71467</link>
		<comments>http://www.stockbloghub.com/2011/04/13/zoll-zoll-medicals-propaq-cleared-in-canada/71467#comments</comments>
		<pubDate>Thu, 14 Apr 2011 02:55:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71467</guid>
		<description><![CDATA[Resuscitation devices maker ZOLL Medical (ZOLL) has secured approval from Health Canada to market its Propaq MD monitor/ defibrillator and Propaq M monitor to military customers and air medical operations in Canada, enabling them to provide advanced critical care to patients. Propaq MD, which was approved in the U.S. in July 2010, is developed in collaboration with the Department of Defense and leading medical diagnostic devices maker Welch Allyn, assisted by grants from the U.S. Army Medical Research and Development Command. The Propaq M, a monitor-only version of the PropaqMD, was cleared in the U.S. in September 2010. It was also developed under the same collaboration. Both devices have been designed to specifically address the tough demands of battlefield medicine and meet an unprecedented number of military and international standards. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/13/zoll-zoll-medicals-propaq-cleared-in-canada/71467/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Ships New AED Plus</title>
		<link>http://www.stockbloghub.com/2011/04/12/zoll-zoll-medical-ships-new-aed-plus/71207</link>
		<comments>http://www.stockbloghub.com/2011/04/12/zoll-zoll-medical-ships-new-aed-plus/71207#comments</comments>
		<pubDate>Tue, 12 Apr 2011 21:04:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71207</guid>
		<description><![CDATA[Massachusetts-based medical devices maker ZOLL Medical (ZOLL) recently began shipping a new version of its AED Plus devices for treating sudden cardiac arrest (“SCA”). This new version is fully compliant with the new American Heart Association (“AHA”) and European Resuscitation Council (“ERC”) guidelines issued in October 2010. SCA, an abrupt loss of cardiac function, is one of the major causes of unexpected deaths. Early defibrillation raises the chances of survival from just 5% to more than 50%. The key change in the new AHA and ERC guidelines is the recommendation for chest compressions that are at least 2 inches deep as opposed to between 1.5 and 2 inches required by the earlier guidelines (issued in 2005). Recent studies have shown significant improvement in survival in SCA victims who have received ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/12/zoll-zoll-medical-ships-new-aed-plus/71207/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook &#8211; April 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413</link>
		<comments>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413#comments</comments>
		<pubDate>Thu, 31 Mar 2011 23:07:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70413</guid>
		<description><![CDATA[Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory environment. Although a number of these issues remain, the industry is expected to fare better this year due to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest medical devices market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical&#8217;s LifeVest Defibrillator Hits Milestone</title>
		<link>http://www.stockbloghub.com/2011/02/18/zoll-zoll-medicals-lifevest-defibrillator-hits-milestone/67030</link>
		<comments>http://www.stockbloghub.com/2011/02/18/zoll-zoll-medicals-lifevest-defibrillator-hits-milestone/67030#comments</comments>
		<pubDate>Fri, 18 Feb 2011 16:39:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67030</guid>
		<description><![CDATA[Resuscitation devices maker ZOLL Medical’s (ZOLL) popular LifeVest wearable defibrillator has reached another key milestone as it has been reportedly prescribed to over 35,000 patients at high risk of sudden cardiac arrest (“SCA”) by their physicians. The achievement underscores the sustained adoption of the device for treating this condition. SCA, an abrupt loss of cardiac function, is one of the major causes of unexpected deaths. According to the American Heart Association, more than 700 people die from this condition each day in the U.S. Early defibrillation raises the chance of survival from just 5% to over 50%. LifeVest is a lightweight device which is worn outside the body (rather than implanted in the chest) by patients at risk of SCA. The device continuously monitors the heart with electrodes (electric conductors) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/18/zoll-zoll-medicals-lifevest-defibrillator-hits-milestone/67030/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL&#8217;s Medical Earnings Per Share Beats Expectations &#8211; Profit Doubles</title>
		<link>http://www.stockbloghub.com/2010/12/06/zoll-zolls-medical-earnings-per-share-beats-expectations-profit-doubles/60023</link>
		<comments>http://www.stockbloghub.com/2010/12/06/zoll-zolls-medical-earnings-per-share-beats-expectations-profit-doubles/60023#comments</comments>
		<pubDate>Tue, 07 Dec 2010 02:38:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=60023</guid>
		<description><![CDATA[Resuscitation devices and software company ZOLL Medical (ZOLL) reported fourth-quarter fiscal 2010 (ended October 3) earnings of 33 cents, beating the Zacks Consensus Estimate of 31 cents and exceeding the year-ago earnings of 16 cents. Net income doubled year over year to $7.2 million. For fiscal 2010, earnings of 87 cents per share also beat the Zacks Consensus Estimate of 85 cents. The results were driven by sustained strong performance of the company’s LifeVest wearable defibrillator business. Revenues for the quarter shot up 12% year over year to $120.4 million, but missed the Zacks Consensus Estimate of $124 million. For fiscal 2010, revenues leapt 15% to $444 million, also below the Zacks Consensus Estimate of $448 million. Sales for the year include a roughly $18.9 million contribution from the Temperature ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/06/zoll-zolls-medical-earnings-per-share-beats-expectations-profit-doubles/60023/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook December 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379</link>
		<comments>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379#comments</comments>
		<pubDate>Tue, 07 Dec 2010 01:15:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61379</guid>
		<description><![CDATA[Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative with 2009 worldwide sales in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, high unmet medical needs and increased incidence of lifestyle diseases (including cardiovascular diseases, diabetes, hypertension and obesity). Neuro, Orthopedic and Aesthetic represent the fastest growing categories. The aging population represents a major catalyst for demand of medical devices. The elderly population (persons 65 years and above) base in the U.S. registered 39.6 million in 2009, representing roughly 13% of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HUM) June 2010 &#8211; Industry Outlook &#8211; Health Care Stock Review</title>
		<link>http://www.stockbloghub.com/2010/06/03/hum-june-2010-industry-outlook-health-care-stock-review/39181</link>
		<comments>http://www.stockbloghub.com/2010/06/03/hum-june-2010-industry-outlook-health-care-stock-review/39181#comments</comments>
		<pubDate>Thu, 03 Jun 2010 13:12:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[MYGN]]></category>
		<category><![CDATA[Myriad Genetics Inc.]]></category>
		<category><![CDATA[Tenet Healthcare Corporation]]></category>
		<category><![CDATA[THC]]></category>
		<category><![CDATA[UIS]]></category>
		<category><![CDATA[Unisys Corporation]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=39181</guid>
		<description><![CDATA[The health care sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors in this sector should be mindful of the different drivers and appropriate metrics associated with the various sub-sectors. In March 2010, U.S. healthcare reform passed through Congress, which aims to expand coverage to 31 million Americans who are currently uninsured. This translates into 31 million more customers for the health insurance industry, and 31 million more people for whom prescriptions might be written. Furthermore, the bill cracks down on insurance company abuses. There are multiple pilot programs in the bill that have the potential to significantly reduce the growth in health care costs. However, most of the provisions of the bill ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/06/03/hum-june-2010-industry-outlook-health-care-stock-review/39181/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Analyst Upgrades to Outperform</title>
		<link>http://www.stockbloghub.com/2010/05/23/zoll-zoll-medical-corporation-analyst-upgrades-to-outperform/37986</link>
		<comments>http://www.stockbloghub.com/2010/05/23/zoll-zoll-medical-corporation-analyst-upgrades-to-outperform/37986#comments</comments>
		<pubDate>Mon, 24 May 2010 04:20:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=37986</guid>
		<description><![CDATA[Recently, we upgraded ZOLL Medical Corporation (ZOLL) to Outperform from Neutral with a price target of $38 primarily driven by the better-than-expected second quarter fiscal 2010 results as released on April 29, 2010. ZOLL Medical Corporation surpassed the Zacks Consensus Estimate by 4 cents in the most recent quarter. The better-than-expected results were driven by the strong performance at its LifeVest business and inclusion of temperature management business. Revenues in the reported quarter went up approximately 15% year over year to $107.1 million. We are pleased with the company&#8217;s wide range of products and its further expansion. As such, ZOLL is the leader in the global market for external defibrillators, which is worth over $1 billion annually. The company is expanding its offerings to sustain growth. We believe that ZOLL’s expansion initiatives ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/23/zoll-zoll-medical-corporation-analyst-upgrades-to-outperform/37986/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2010/05/23/zoll-zoll-medical-earnings-scorecard/38005</link>
		<comments>http://www.stockbloghub.com/2010/05/23/zoll-zoll-medical-earnings-scorecard/38005#comments</comments>
		<pubDate>Mon, 24 May 2010 04:12:36 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38005</guid>
		<description><![CDATA[Following the release of second quarter fiscal 2010 (ended April 4, 2010) results on April 29, 2010, majority of the analysts covering ZOLL Medical Corporation (ZOLL) have made upward revisions to their 2010 and 2011 annual estimates. The company performed impressively in the quarter, beating the Zacks Consensus Earnings Estimate by 4 cents. We upgraded the stock to Outperform from Neutral following its impressive showing in the most recent quarter, its wide range of products and its expanding international presence. Earnings Report Review ZOLL Medical Corporation’s second quarter fiscal 2010 earnings of $0.17 per share surpassed the Zacks Consensus Estimate by $0.04. The better-than-expected results were driven by the strong showing of its LifeVest business and inclusion of its temperature management business. Revenues in the reported quarter climbed approximately 15% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/23/zoll-zoll-medical-earnings-scorecard/38005/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2010/05/17/zoll-zoll-medical-corporation-bull-of-the-day-2/37325</link>
		<comments>http://www.stockbloghub.com/2010/05/17/zoll-zoll-medical-corporation-bull-of-the-day-2/37325#comments</comments>
		<pubDate>Mon, 17 May 2010 15:07:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=37325</guid>
		<description><![CDATA[ZOLL Medical Corporation&#8217;s (ZOLL) second quarter fiscal 2010 earnings of $0.17 per share surpassed the Zacks Consensus Estimate by $0.04. The better-than-expected results were driven by the strong showing of its LifeVest business and inclusion of its temperature management business. We are pleased with the company&#8217;s wide range of products. Its significant international presence should also drive growth. ZOLL has made multiple acquisitions in the past which have aided growth and the company is looking for more such opportunities. Consequently, we upgrade the stock to Outperform with a target of $38. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/17/zoll-zoll-medical-corporation-bull-of-the-day-2/37325/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Report Tops Consensus</title>
		<link>http://www.stockbloghub.com/2010/05/03/zoll-zoll-medical-corporation-report-tops-consensus/35816</link>
		<comments>http://www.stockbloghub.com/2010/05/03/zoll-zoll-medical-corporation-report-tops-consensus/35816#comments</comments>
		<pubDate>Mon, 03 May 2010 22:05:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=35816</guid>
		<description><![CDATA[ZOLL Medical Corp.’s (ZOLL) second quarter fiscal 2010 (ended Apr 4, 2010) earnings of 17 cents per share surpassed the Zacks Consensus Estimate by 4 cents. The company earned 8 cents per share in the year-ago quarter. The better-than-expected results were driven by strong showing of its LifeVest business and inclusion of its Temperature Management business. Revenues in the reported quarter climbed approximately 15% year-over-year to $107.1 million. Revenue for the quarter reflected a positive foreign exchange impact of approximately $2.2 million, compared to the year-ago quarter and included approximately $4 million from the acquisition of the Temperature Management business. While sales in the North American market climbed approximately 16% year-over-year to $81 million during the reported quarter. International sales, which included $1.7 million related to Temperature Management, came in at ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/03/zoll-zoll-medical-corporation-report-tops-consensus/35816/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) Health Care Outlook &amp; Stock Review &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/03/04/wlp-health-care-outlook-stock-review-industry-outlook/29684</link>
		<comments>http://www.stockbloghub.com/2010/03/04/wlp-health-care-outlook-stock-review-industry-outlook/29684#comments</comments>
		<pubDate>Thu, 04 Mar 2010 16:44:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[Health Net Inc.]]></category>
		<category><![CDATA[HNT]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29684</guid>
		<description><![CDATA[OVERVIEW The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors in this sector should be mindful of the different drivers and appropriate metrics associated with the various sub-sectors. In the present scenario, investor sentiment in healthcare continues to be driven by decisions in the Congress related to government funding and the state of the broader economy. In view of the ongoing healthcare reform debate in the Congress, healthcare policy changes remain an important indicator to investing in the sector. The Health Bill intends to cover nearly all Americans by providing government subsidies to help pay premiums irrespective of health or income. President Obama has made a last-ditch effort to revive the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/04/wlp-health-care-outlook-stock-review-industry-outlook/29684/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Analysts Downgrade to Neutral</title>
		<link>http://www.stockbloghub.com/2010/01/13/zoll-zoll-medical-corporation-analysts-downgrade-to-neutral/24896</link>
		<comments>http://www.stockbloghub.com/2010/01/13/zoll-zoll-medical-corporation-analysts-downgrade-to-neutral/24896#comments</comments>
		<pubDate>Wed, 13 Jan 2010 23:59:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cardiac Science Corporation]]></category>
		<category><![CDATA[CSCX]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24896</guid>
		<description><![CDATA[We have downgraded ZOLL Medical Corporation (ZOLL) to Neutral from Outperform with a price target of $29.50. Even though we are pleased with the company’s significant international presence &#8212; which coupled with its wide range of products also drive growth &#8211; the intense competition confronting its products concern us. Furthermore, ZOLL’s strategy of growth by acquisition has inherent risks. Headquartered in Chelmsford, Massachusetts, and founded in 1980, ZOLL Medical Corporation designs, manufactures, markets and sells non-invasive resuscitation devices and related software solutions both in the U.S. and overseas. The solutions include defibrillation devices with/without the pacing option, such as ZOLL&#8217;s M Series, E Series, R Series, automated external defibrillator (AED) Plus, AED Pro, and LifeVest Wearable Defibrillator. Furthermore, these solutions include a circulatory assist device called AutoPulse. The product pipeline also ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/13/zoll-zoll-medical-corporation-analysts-downgrade-to-neutral/24896/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation &#8211; Fourth-Quarter Results Beat by 100%</title>
		<link>http://www.stockbloghub.com/2010/01/05/zoll-zoll-medical-corporation-fourth-quarter-results-beat-by-100/24136</link>
		<comments>http://www.stockbloghub.com/2010/01/05/zoll-zoll-medical-corporation-fourth-quarter-results-beat-by-100/24136#comments</comments>
		<pubDate>Tue, 05 Jan 2010 18:38:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24136</guid>
		<description><![CDATA[ZOLL Medical Corp. (ZOLL) just hit a new 52-week high on continued momentum from the company&#8217;s better than expected Q4 results from early November. Company Description ZOLL Medical Corp., together with its subsidiaries, develops and sells specialized medical devices and software solutions in the United States and Internationally. The company was founded in 1980 and has a market cap of $578 million. Shares of ZOLL are once again pressuring the 52-week high after rebounding from a short-term level of support just above $26. ZOLL has been surging since early November when the company reported better than expected Q4 results. Fourth-Quarter Results Sales were up 2% from last year to $108 million. Earnings were also strong at 16 cents per share, 8 cents ahead of the Zacks Consensus Estimate. The company ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/05/zoll-zoll-medical-corporation-fourth-quarter-results-beat-by-100/24136/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Earns FDA Clearance</title>
		<link>http://www.stockbloghub.com/2010/01/01/zoll-zoll-medical-corporation-earns-fda-clearance/24040</link>
		<comments>http://www.stockbloghub.com/2010/01/01/zoll-zoll-medical-corporation-earns-fda-clearance/24040#comments</comments>
		<pubDate>Sat, 02 Jan 2010 02:28:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24040</guid>
		<description><![CDATA[Recently, ZOLL Medical Corporation (ZOLL) announced that the U.S. Food and Drug Administration (FDA) approved the marketing of its E series defibrillators equipped with carbon monoxide (CO) monitoring. The new model of the ZOLL E series monitor/defibrillator is available for shipment with immediate effect. The presence of CO monitoring in the new model is an impressive feature. It will protect firefighters, civilians and treat patients poisoned by CO immediately. If someone is continuously exposed to the gas then his heart and brain are liable to be affected in the long term. Furthermore, a solitary severe case of CO poisoning almost doubles the risk of premature demise. People poisoned by this gas often display flu-like symptoms. However, it is also possible that people poisoned by this “silent killer&#8221; do not display ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/01/zoll-zoll-medical-corporation-earns-fda-clearance/24040/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(UNH) Healthcare Stock Review &#8211; December 2009 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2009/12/17/unh-healthcare-stock-review-dec-2009-industry-outlook/23150</link>
		<comments>http://www.stockbloghub.com/2009/12/17/unh-healthcare-stock-review-dec-2009-industry-outlook/23150#comments</comments>
		<pubDate>Fri, 18 Dec 2009 00:58:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Amgen Inc]]></category>
		<category><![CDATA[AMGN]]></category>
		<category><![CDATA[BIOS]]></category>
		<category><![CDATA[BioScrip Inc.]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Hologic Inc]]></category>
		<category><![CDATA[HOLX]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[LMNX]]></category>
		<category><![CDATA[Luminex Corporation]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Perrigo Company]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[Polypore International Inc]]></category>
		<category><![CDATA[PPO]]></category>
		<category><![CDATA[PRGO]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23150</guid>
		<description><![CDATA[OVERVIEW The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors in this sector should be mindful of the different drivers and appropriate metrics associated with the various sub-sectors. In the present scenario, investor sentiment in healthcare continues to be driven by decisions in Congress related to government funding and the state of the broader economy. In view of the ongoing healthcare reform debate in Congress, healthcare policy changes remain an important indicator to investing in the sector. Even though legislation &#8212; which aims to cover nearly all Americans by providing government subsidies to help pay premiums irrespective of health or income &#8212; was passed in the House of Representatives, it is ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/17/unh-healthcare-stock-review-dec-2009-industry-outlook/23150/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2009/12/16/zoll-zoll-medical-corporation-bull-of-the-day/22959</link>
		<comments>http://www.stockbloghub.com/2009/12/16/zoll-zoll-medical-corporation-bull-of-the-day/22959#comments</comments>
		<pubDate>Wed, 16 Dec 2009 17:28:47 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22959</guid>
		<description><![CDATA[ZOLL Medical Corporation (ZOLL) reported fourth quarter earnings of 16 cents per share, beating the Zacks Consensus Estimate of 8 cents. The company earned 41 cents per share in the year-ago quarter. For fiscal 2009, the company earned 45 cents per share, which also exceeded the Zacks Consensus Estimate by 8 cents but was well below the year-ago earnings of $1.10. We are pleased with the company&#8217;s wide range of products and significant international presence. ZOLL has made multiple acquisitions in the past which have aided growth, and the company is looking for more such opportunities. Consequently, we upgrade the stock to Outperform with a target of $31. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/16/zoll-zoll-medical-corporation-bull-of-the-day/22959/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Corporation Upgraded to Outperform</title>
		<link>http://www.stockbloghub.com/2009/12/15/zoll-zoll-medical-corporation-upgraded-to-outperform/22908</link>
		<comments>http://www.stockbloghub.com/2009/12/15/zoll-zoll-medical-corporation-upgraded-to-outperform/22908#comments</comments>
		<pubDate>Wed, 16 Dec 2009 05:28:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22908</guid>
		<description><![CDATA[We are upgrading ZOLL Medical Corp. (ZOLL) to Outperform from Neutral. We are pleased with the company’s wide range of products and significant international presence. The company has made multiple acquisitions in the past, which have aided growth and is looking out for more such opportunities. Headquartered in Chelmsford, Massachusetts, and founded in 1980, ZOLL Medical Corporation designs, manufactures, markets and sells non-invasive resuscitation devices and related software solutions both in the U.S. and overseas. The solutions include defibrillation devices with/without the pacing option, such as ZOLL&#8217;s M Series, E Series, R Series, automated external defibrillator (AED) Plus, AED Pro, and LifeVest Wearable Defibrillator. Furthermore, these solutions include a circulatory assist device called AutoPulse. The product pipeline also includes a unique fluid resuscitation product, called the Power Infuser, manufactured by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/15/zoll-zoll-medical-corporation-upgraded-to-outperform/22908/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL Medical Beats Expectations in Recent Quarter</title>
		<link>http://www.stockbloghub.com/2009/11/12/zoll-zoll-medical-beats-expectations-in-recent-quarter/20374</link>
		<comments>http://www.stockbloghub.com/2009/11/12/zoll-zoll-medical-beats-expectations-in-recent-quarter/20374#comments</comments>
		<pubDate>Thu, 12 Nov 2009 16:17:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Cardiac Science Corporation]]></category>
		<category><![CDATA[CSCX]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV]]></category>
		<category><![CDATA[PHG]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20374</guid>
		<description><![CDATA[ZOLL Medical Corp. (ZOLL) reported fourth-quarter earnings of 16 cents per share, which beat the Zacks Consensus Estimate of 8 cents. The company earned 41 cents in the year-ago quarter. The lower profit in the quarter was attributable to lower margins coupled with higher expenses, in spite of higher revenues. For full fiscal 2009, the company earned 45 cents per share, which exceeded the Zacks Consensus Estimate by 8 cents but was well below the year-ago earnings of $1.10. Quarterly Results Revenues in the reported quarter came in at $107.87 million from $105.60 million in the year ago quarter, up 2%. Revenue for the quarter reflected a negative foreign exchange impact of approximately $1.4 million and included approximately $5 million from the acquisition of the Temperature Management business. Sales in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/12/zoll-zoll-medical-beats-expectations-in-recent-quarter/20374/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ZOLL) ZOLL&#8217;s New Wearable Defibrillator Approved</title>
		<link>http://www.stockbloghub.com/2009/08/25/zoll-zolls-new-wearable-defibrillator-approved/13337</link>
		<comments>http://www.stockbloghub.com/2009/08/25/zoll-zolls-new-wearable-defibrillator-approved/13337#comments</comments>
		<pubDate>Tue, 25 Aug 2009 20:42:04 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13337</guid>
		<description><![CDATA[ZOLL Medical (ZOLL) obtained clearance from the U.S. Food and Drug Administration (FDA) for its new model of the LifeVest wearable defibrillator. The physicians advise LifeVest for their patients, who run the risk of sudden cardiac arrest. LifeVest enables physicians to assess the long-term arrhythmic risk in their patients and take suitable actions. ZOLL rents out LifeVest to patients like other durable medical equipments. ZOLL’s LifeVest business continues to grow strongly despite constrained capital spending by healthcare providers. LifeVest revenues increased 58% year over year to $11.9 million during its fiscal third quarter, while total revenues declined 5%. More than 2,900 physicians have recommended the product in the current fiscal. Presently, over 2,000 patients are using LifeVest. With growing clinical acceptance, ZOLL is optimistic about the growth prospect of this ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/25/zoll-zolls-new-wearable-defibrillator-approved/13337/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

